Welcome to our dedicated page for Trulieve Cannabis news (Ticker: TCNNF), a resource for investors and traders seeking the latest updates and insights on Trulieve Cannabis stock.
Trulieve Cannabis Corp (TCNNF) provides comprehensive medical and recreational cannabis products through its vertically integrated operations across multiple U.S. states. This news hub offers investors and stakeholders direct access to official corporate announcements, financial disclosures, and operational updates.
Discover timely information about earnings reports, regulatory compliance milestones, dispensary expansions, and product innovations. Our curated collection ensures transparent tracking of Trulieve's market leadership in cultivation practices and retail operations within strictly regulated environments.
Key updates include strategic acquisitions, new market entries, sustainability initiatives, and advancements in medical cannabis research. All content originates from verified company communications to maintain accuracy and compliance with financial disclosure standards.
Bookmark this page for streamlined monitoring of TCNNF's operational developments and industry positioning. Check regularly for updates on one of the cannabis sector's most influential multi-state operators.
Trulieve Cannabis Corp. has opened a new medical dispensary in Apopka, Florida, enhancing patient access to cannabis products. The dispensary, located at 2121 W Orange Blossom Trail, offers regular hours from 9am to 9pm, and provides various discounts including 25% for registered patients and 50% for first-time guests. The grand opening on July 9, 2022, features festivities and multiple partner giveaways. Known as a leading cannabis provider in Florida, Trulieve offers a vast selection of THC and CBD products, alongside personalized patient care and support.
Trulieve Cannabis Corp. announced the opening of a new medical dispensary in Hurricane, West Virginia, on July 6, 2022. This marks the company’s sixth location in the state, which has seen a surge of nearly 10,000 registered medical cannabis patients in less than a year. The grand opening celebration is scheduled for July 9, featuring special offers for patients, including a 25% discount. Trulieve continues to expand its presence with plans for more dispensaries in West Virginia, providing a wide range of THC and CBD products to meet the needs of local patients.
Trulieve Cannabis Corp. announced the opening of a new medical dispensary in Coral Springs, Florida, on July 1, 2022. This facility will operate seven days a week, enhancing patient access to medical cannabis. The grand opening features various festivities and a 25% discount for all registered patients. Trulieve emphasizes its commitment to quality products and personalized patient care, offering a wide range of THC and CBD products. The company operates in 11 states and is a leading cannabis provider with a focus on expanding access and customer experience.
Trulieve Cannabis Corp. held its Annual Meeting of Shareholders on June 8, 2022, where resolutions were approved to elect eight directors and reappoint Marcum LLP as auditors. A total of 97,288,636 votes were cast, representing 52.8% of outstanding shares. The elected directors are Kim Rivers, Giannella Alvarez, Thad Beshears, Peter Healy, Richard May, Thomas Millner, Jane Morreau, and Susan Thronson. The company, operating in 11 states and a leading cannabis operator, aims for growth and market expansion.
Trulieve Cannabis Corp. (OTCQX: TCNNF) announces its participation in several upcoming conferences in June 2022. Key events include the 19th Annual Craig-Hallum Institutional Investor Conference on June 1, the Jefferies Cannabis Summit on June 2 in New York, an Analyst Event with a bus tour in Florida on June 7, and the Annual Shareholder Meeting on June 8, accessible online. Trulieve, a leading cannabis company operating in 11 states, is focused on growth through its hub strategy and aims to provide high-quality products to enhance customer experience.
Trulieve Cannabis Corp. (OTCQX: TCNNF) reported record revenue of $318.3 million for Q1 2022, marking a 64% increase year-over-year and a 4% rise sequentially. The gross profit reached $178.2 million with a gross margin of 56%. Despite a net loss of $32.0 million, adjusted net income was $1.7 million. Operationally, Trulieve has an extensive retail network with 165 dispensaries and over 4.0 million square feet of cultivation capacity. The company expects 2022 revenue between $1.3 billion and $1.4 billion.
Trulieve Cannabis Corp. (CSE: TRUL; OTCQX: TCNNF) announced its participation in May 2022 events, highlighting a keynote speech by CEO Kim Rivers at Regenerative Cannabis Live on May 5, 2022. Trulieve is a leading, vertically integrated cannabis company operating in 11 states, focusing on growth and market expansion through its hub strategy. The company aims to provide innovative, high-quality products to enhance customer experiences and access to cannabis.
On April 28, 2022, Trulieve Cannabis Corp. announced that CEO Kim Rivers received the Women's Leadership Award from Green Market Report for her contributions in the cannabis industry. Rivers has driven significant business advancements, including leading retail expansion and the acquisition of Harvest Health. Trulieve also released its first ESG report, marking a milestone in corporate responsibility. The award ceremony took place during the Women's Summit in New York City, highlighting the importance of female leadership in the cannabis sector.
FAQ
What is the current stock price of Trulieve Cannabis (TCNNF)?
What is the market cap of Trulieve Cannabis (TCNNF)?
